CMDh_269_2012_Rev0_2012 10 (republished)

First Page		Document Content
Date: 2016-07-27 08:07:45 Pharmaceutical industry Pharmaceutical sciences Pharmacology Pharmaceuticals policy Health Directive 2001/83/EC Biopharmaceutical Denatured alcohol Marketing authorization Pharmaceutical drug		CMDh_269_2012_Rev0_2012 10 (republished) Add to Reading List Source URL: www.hma.eu Download Document from Source Website File Size: 70,96 KB Share Document on Facebook

	INDUSTRY ISSUES What Is a Biopharmaceutical? DocID: 1v8Wa - View Document
	Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical DocID: 1v7ko - View Document
	INDUSTRY ISSUES What Is a Biopharmaceutical? DocID: 1v72B - View Document
	Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell DocID: 1v5W2 - View Document
	TERMINOLOGY What is a Biopharmaceutical? DocID: 1v5mX - View Document